Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-D-aspartate (NMDA) receptors genes in relevant brain regions
Identifieur interne : 000740 ( PascalFrancis/Corpus ); précédent : 000739; suivant : 000741Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-D-aspartate (NMDA) receptors genes in relevant brain regions
Auteurs : Nathalie Grova ; Henri Schroeder ; Sophie Farinelle ; Emmanuel Prodhomme ; Anne Valley ; Claude P. MullerSource :
- Chemosphere : (Oxford) [ 0045-6535 ] ; 2008.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Abnormal glutamatergic transmission caused by modulation of N-methyl-D-aspartate (NMDA) receptors was demonstrated in animal models chronically exposed to various organic micropollutants. Recent developments in neurobiology have implicated these receptors in the regulation of anxiety. In order to investigate anxiety-related effects of benzo[a]pyrene (B[a]P), Balb/c mice were sub-acutely exposed to B[a]P (0.02-200 mg kg-1 day-1, 10 days, i.p.). Their performance was tested in the elevated-plus maze and the hole-board apparatus and the NMDA receptor expression genes (NR1, 2A and 2B subunits) was measured in eight brain regions. Mice treated with 20-200mg kg-1 B[a]P showed a disproportionate accumulation of B[a]P and its metabolites (in particular, the toxic 7,8-diol-B[a]P) in the blood and even more in the brain. These mice were less anxious than controls in the hole-board test and the elevated-plus maze. This observation was associated with an overexpression of the NMDA NR1 receptor gene and concomitant decreases of the NR2A and NR2B subunits expression in the hippocampus, the hypothalamus and the cerebellum. In the temporal cortex, a significant dose-related decrease of NR2A was observed whereas the other subunits remained unchanged. In conclusion, a sub-acute exposure to B[a]P (20 and 200 mg kg-1) reduced anxiety-related behaviour in adult mice and concomitantly impaired NMDA receptor gene expression in relevant brain regions.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
pR |
|
Format Inist (serveur)
NO : | PASCAL 09-0021305 INIST |
---|---|
ET : | Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-D-aspartate (NMDA) receptors genes in relevant brain regions |
AU : | GROVA (Nathalie); SCHROEDER (Henri); FARINELLE (Sophie); PRODHOMME (Emmanuel); VALLEY (Anne); MULLER (Claude P.); ALAEE (Mehran); ARSENAULT (Gilles); PARROTT (Joanne); REINER (Eric J.) |
AF : | Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102/1011 Luxembourg/Luxembourg (1 aut., 3 aut., 4 aut., 6 aut.); Neurosciences Comportementales, URAFPA. INRA UC340, Nancy Université, BP 239/54506 Vandoeuvre les Nancy/France (2 aut., 5 aut.); Department of Immunology, The Graduate School of Psychobiology, University of Trier/54290 Trier/Allemagne (6 aut.); Water Science and Technology Branch, Environmental Canada/Burlington/Canada (1 aut., 3 aut.); Wellington Laboratories/Guelph/Canada (2 aut.); Laboratory Services Branch, Ontario Ministry of Environment/Toronto/Canada (4 aut.) |
DT : | Publication en série; Congrès; Niveau analytique |
SO : | Chemosphere : (Oxford); ISSN 0045-6535; Coden CMSHAF; Royaume-Uni; Da. 2008; Vol. 73; No. SUP1; S295-S302; Bibl. 3/4 p. |
LA : | Anglais |
EA : | Abnormal glutamatergic transmission caused by modulation of N-methyl-D-aspartate (NMDA) receptors was demonstrated in animal models chronically exposed to various organic micropollutants. Recent developments in neurobiology have implicated these receptors in the regulation of anxiety. In order to investigate anxiety-related effects of benzo[a]pyrene (B[a]P), Balb/c mice were sub-acutely exposed to B[a]P (0.02-200 mg kg-1 day-1, 10 days, i.p.). Their performance was tested in the elevated-plus maze and the hole-board apparatus and the NMDA receptor expression genes (NR1, 2A and 2B subunits) was measured in eight brain regions. Mice treated with 20-200mg kg-1 B[a]P showed a disproportionate accumulation of B[a]P and its metabolites (in particular, the toxic 7,8-diol-B[a]P) in the blood and even more in the brain. These mice were less anxious than controls in the hole-board test and the elevated-plus maze. This observation was associated with an overexpression of the NMDA NR1 receptor gene and concomitant decreases of the NR2A and NR2B subunits expression in the hippocampus, the hypothalamus and the cerebellum. In the temporal cortex, a significant dose-related decrease of NR2A was observed whereas the other subunits remained unchanged. In conclusion, a sub-acute exposure to B[a]P (20 and 200 mg kg-1) reduced anxiety-related behaviour in adult mice and concomitantly impaired NMDA receptor gene expression in relevant brain regions. |
CC : | 002B03L06 |
FD : | Benzo pyrène; Subaigu; Benzo[a]pyrène; Comportement; Animal adulte; Souris; NMDA; Angoisse anxiété; Récepteur NMDA; Gène; Encéphale; Récepteur glutamate; Sousunité; Sang; Composé aromatique polycyclique; Hydrocarbure; Mécanisme action; Toxicité |
FG : | Rodentia; Mammalia; Vertebrata; Polluant organique persistant; Composé organique; Affect affectivité |
ED : | Benzopyrene; Subacute; Behavior; Adult animal; Mouse; NMDA; Anxiety; NMDA receptor; Gene; Encephalon; Glutamate receptor; Subunit; Blood; Polycyclic aromatic compound; Hydrocarbon; Mechanism of action; Toxicity |
EG : | Rodentia; Mammalia; Vertebrata; Persistent organic pollutant; Organic compounds; Affect affectivity |
SD : | Benzopireno; Subagudo; Conducta; Animal adulto; Ratón; NMDA; Angustia ansiedad; Receptor NMDA; Gen; Encéfalo; Receptor glutámato; Subunitad; Sangre; Compuesto aromático policíclico; Hidrocarburo; Mecanismo acción; Toxicidad |
LO : | INIST-15565.354000185279380450 |
ID : | 09-0021305 |
Links to Exploration step
Pascal:09-0021305Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-D-aspartate (NMDA) receptors genes in relevant brain regions</title>
<author><name sortKey="Grova, Nathalie" sort="Grova, Nathalie" uniqKey="Grova N" first="Nathalie" last="Grova">Nathalie Grova</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102</s1>
<s2>1011 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schroeder, Henri" sort="Schroeder, Henri" uniqKey="Schroeder H" first="Henri" last="Schroeder">Henri Schroeder</name>
<affiliation><inist:fA14 i1="02"><s1>Neurosciences Comportementales, URAFPA. INRA UC340, Nancy Université, BP 239</s1>
<s2>54506 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Farinelle, Sophie" sort="Farinelle, Sophie" uniqKey="Farinelle S" first="Sophie" last="Farinelle">Sophie Farinelle</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102</s1>
<s2>1011 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Prodhomme, Emmanuel" sort="Prodhomme, Emmanuel" uniqKey="Prodhomme E" first="Emmanuel" last="Prodhomme">Emmanuel Prodhomme</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102</s1>
<s2>1011 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valley, Anne" sort="Valley, Anne" uniqKey="Valley A" first="Anne" last="Valley">Anne Valley</name>
<affiliation><inist:fA14 i1="02"><s1>Neurosciences Comportementales, URAFPA. INRA UC340, Nancy Université, BP 239</s1>
<s2>54506 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Muller, Claude P" sort="Muller, Claude P" uniqKey="Muller C" first="Claude P." last="Muller">Claude P. Muller</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102</s1>
<s2>1011 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Immunology, The Graduate School of Psychobiology, University of Trier</s1>
<s2>54290 Trier</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0021305</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 09-0021305 INIST</idno>
<idno type="RBID">Pascal:09-0021305</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000740</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-D-aspartate (NMDA) receptors genes in relevant brain regions</title>
<author><name sortKey="Grova, Nathalie" sort="Grova, Nathalie" uniqKey="Grova N" first="Nathalie" last="Grova">Nathalie Grova</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102</s1>
<s2>1011 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schroeder, Henri" sort="Schroeder, Henri" uniqKey="Schroeder H" first="Henri" last="Schroeder">Henri Schroeder</name>
<affiliation><inist:fA14 i1="02"><s1>Neurosciences Comportementales, URAFPA. INRA UC340, Nancy Université, BP 239</s1>
<s2>54506 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Farinelle, Sophie" sort="Farinelle, Sophie" uniqKey="Farinelle S" first="Sophie" last="Farinelle">Sophie Farinelle</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102</s1>
<s2>1011 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Prodhomme, Emmanuel" sort="Prodhomme, Emmanuel" uniqKey="Prodhomme E" first="Emmanuel" last="Prodhomme">Emmanuel Prodhomme</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102</s1>
<s2>1011 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valley, Anne" sort="Valley, Anne" uniqKey="Valley A" first="Anne" last="Valley">Anne Valley</name>
<affiliation><inist:fA14 i1="02"><s1>Neurosciences Comportementales, URAFPA. INRA UC340, Nancy Université, BP 239</s1>
<s2>54506 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Muller, Claude P" sort="Muller, Claude P" uniqKey="Muller C" first="Claude P." last="Muller">Claude P. Muller</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102</s1>
<s2>1011 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Immunology, The Graduate School of Psychobiology, University of Trier</s1>
<s2>54290 Trier</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Chemosphere : (Oxford)</title>
<title level="j" type="abbreviated">Chemosphere : (Oxf.)</title>
<idno type="ISSN">0045-6535</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Chemosphere : (Oxford)</title>
<title level="j" type="abbreviated">Chemosphere : (Oxf.)</title>
<idno type="ISSN">0045-6535</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult animal</term>
<term>Anxiety</term>
<term>Behavior</term>
<term>Benzopyrene</term>
<term>Blood</term>
<term>Encephalon</term>
<term>Gene</term>
<term>Glutamate receptor</term>
<term>Hydrocarbon</term>
<term>Mechanism of action</term>
<term>Mouse</term>
<term>NMDA</term>
<term>NMDA receptor</term>
<term>Polycyclic aromatic compound</term>
<term>Subacute</term>
<term>Subunit</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Benzo pyrène</term>
<term>Subaigu</term>
<term>Benzo[a]pyrène</term>
<term>Comportement</term>
<term>Animal adulte</term>
<term>Souris</term>
<term>NMDA</term>
<term>Angoisse anxiété</term>
<term>Récepteur NMDA</term>
<term>Gène</term>
<term>Encéphale</term>
<term>Récepteur glutamate</term>
<term>Sousunité</term>
<term>Sang</term>
<term>Composé aromatique polycyclique</term>
<term>Hydrocarbure</term>
<term>Mécanisme action</term>
<term>Toxicité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abnormal glutamatergic transmission caused by modulation of N-methyl-D-aspartate (NMDA) receptors was demonstrated in animal models chronically exposed to various organic micropollutants. Recent developments in neurobiology have implicated these receptors in the regulation of anxiety. In order to investigate anxiety-related effects of benzo[a]pyrene (B[a]P), Balb/c mice were sub-acutely exposed to B[a]P (0.02-200 mg kg<sup>-1</sup>
day<sup>-1</sup>
, 10 days, i.p.). Their performance was tested in the elevated-plus maze and the hole-board apparatus and the NMDA receptor expression genes (NR1, 2A and 2B subunits) was measured in eight brain regions. Mice treated with 20-200mg kg<sup>-1</sup>
B[a]P showed a disproportionate accumulation of B[a]P and its metabolites (in particular, the toxic 7,8-diol-B[a]P) in the blood and even more in the brain. These mice were less anxious than controls in the hole-board test and the elevated-plus maze. This observation was associated with an overexpression of the NMDA NR1 receptor gene and concomitant decreases of the NR2A and NR2B subunits expression in the hippocampus, the hypothalamus and the cerebellum. In the temporal cortex, a significant dose-related decrease of NR2A was observed whereas the other subunits remained unchanged. In conclusion, a sub-acute exposure to B[a]P (20 and 200 mg kg<sup>-1</sup>
) reduced anxiety-related behaviour in adult mice and concomitantly impaired NMDA receptor gene expression in relevant brain regions.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0045-6535</s0>
</fA01>
<fA02 i1="01"><s0>CMSHAF</s0>
</fA02>
<fA03 i2="1"><s0>Chemosphere : (Oxf.)</s0>
</fA03>
<fA05><s2>73</s2>
</fA05>
<fA06><s3>SUP1</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-D-aspartate (NMDA) receptors genes in relevant brain regions</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Halogenated Persistent Organic Pollutants - Dioxin 2005 Toronto</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>GROVA (Nathalie)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SCHROEDER (Henri)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>FARINELLE (Sophie)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>PRODHOMME (Emmanuel)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>VALLEY (Anne)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>MULLER (Claude P.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>ALAEE (Mehran)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>ARSENAULT (Gilles)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1"><s1>PARROTT (Joanne)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1"><s1>REINER (Eric J.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102</s1>
<s2>1011 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Neurosciences Comportementales, URAFPA. INRA UC340, Nancy Université, BP 239</s1>
<s2>54506 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Immunology, The Graduate School of Psychobiology, University of Trier</s1>
<s2>54290 Trier</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Water Science and Technology Branch, Environmental Canada</s1>
<s2>Burlington</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Wellington Laboratories</s1>
<s2>Guelph</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="03"><s1>Laboratory Services Branch, Ontario Ministry of Environment</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>4 aut.</sZ>
</fA15>
<fA20><s2>S295-S302</s2>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>15565</s2>
<s5>354000185279380450</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>3/4 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0021305</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Chemosphere : (Oxford)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Abnormal glutamatergic transmission caused by modulation of N-methyl-D-aspartate (NMDA) receptors was demonstrated in animal models chronically exposed to various organic micropollutants. Recent developments in neurobiology have implicated these receptors in the regulation of anxiety. In order to investigate anxiety-related effects of benzo[a]pyrene (B[a]P), Balb/c mice were sub-acutely exposed to B[a]P (0.02-200 mg kg<sup>-1</sup>
day<sup>-1</sup>
, 10 days, i.p.). Their performance was tested in the elevated-plus maze and the hole-board apparatus and the NMDA receptor expression genes (NR1, 2A and 2B subunits) was measured in eight brain regions. Mice treated with 20-200mg kg<sup>-1</sup>
B[a]P showed a disproportionate accumulation of B[a]P and its metabolites (in particular, the toxic 7,8-diol-B[a]P) in the blood and even more in the brain. These mice were less anxious than controls in the hole-board test and the elevated-plus maze. This observation was associated with an overexpression of the NMDA NR1 receptor gene and concomitant decreases of the NR2A and NR2B subunits expression in the hippocampus, the hypothalamus and the cerebellum. In the temporal cortex, a significant dose-related decrease of NR2A was observed whereas the other subunits remained unchanged. In conclusion, a sub-acute exposure to B[a]P (20 and 200 mg kg<sup>-1</sup>
) reduced anxiety-related behaviour in adult mice and concomitantly impaired NMDA receptor gene expression in relevant brain regions.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B03L06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Benzo pyrène</s0>
<s2>NK</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Benzopyrene</s0>
<s2>NK</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Benzopireno</s0>
<s2>NK</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Subaigu</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Subacute</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Subagudo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Benzo[a]pyrène</s0>
<s2>NK</s2>
<s2>FX</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Comportement</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Behavior</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Conducta</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Animal adulte</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Adult animal</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Animal adulto</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Souris</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Mouse</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Ratón</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>NMDA</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>NMDA</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>NMDA</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Angoisse anxiété</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Anxiety</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Angustia ansiedad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Récepteur NMDA</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>NMDA receptor</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Receptor NMDA</s0>
<s5>11</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Gène</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Gene</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Gen</s0>
<s5>12</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Encéphale</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Encephalon</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Encéfalo</s0>
<s5>16</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Récepteur glutamate</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Glutamate receptor</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Receptor glutámato</s0>
<s5>17</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Sousunité</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Subunit</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Subunitad</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Sang</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Blood</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Sangre</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Composé aromatique polycyclique</s0>
<s2>FX</s2>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Polycyclic aromatic compound</s0>
<s2>FX</s2>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Compuesto aromático policíclico</s0>
<s2>FX</s2>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Hydrocarbure</s0>
<s2>FX</s2>
<s5>21</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Hydrocarbon</s0>
<s2>FX</s2>
<s5>21</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Hidrocarburo</s0>
<s2>FX</s2>
<s5>21</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Mécanisme action</s0>
<s5>22</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Mechanism of action</s0>
<s5>22</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Mecanismo acción</s0>
<s5>22</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE"><s0>Toxicité</s0>
<s5>23</s5>
</fC03>
<fC03 i1="18" i2="X" l="ENG"><s0>Toxicity</s0>
<s5>23</s5>
</fC03>
<fC03 i1="18" i2="X" l="SPA"><s0>Toxicidad</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Polluant organique persistant</s0>
<s5>61</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Persistent organic pollutant</s0>
<s5>61</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Contaminante organico persistente</s0>
<s5>61</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Composé organique</s0>
<s2>NA</s2>
<s5>62</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Organic compounds</s0>
<s2>NA</s2>
<s5>62</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Compuesto orgánico</s0>
<s2>NA</s2>
<s5>62</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Affect affectivité</s0>
<s5>63</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Affect affectivity</s0>
<s5>63</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Afecto afectividad</s0>
<s5>63</s5>
</fC07>
<fN21><s1>012</s1>
</fN21>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>International Symposium on halogenated environmental organic pollutants and POPs (Dioxin 2005)</s1>
<s2>25</s2>
<s3>Toronto CAN</s3>
<s4>2005-08-21</s4>
</fA30>
</pR>
</standard>
<server><NO>PASCAL 09-0021305 INIST</NO>
<ET>Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-D-aspartate (NMDA) receptors genes in relevant brain regions</ET>
<AU>GROVA (Nathalie); SCHROEDER (Henri); FARINELLE (Sophie); PRODHOMME (Emmanuel); VALLEY (Anne); MULLER (Claude P.); ALAEE (Mehran); ARSENAULT (Gilles); PARROTT (Joanne); REINER (Eric J.)</AU>
<AF>Institute of Immunology, Laboratoire National de Santé, 20A Rue Auguste Lumière, P.O. Box 1102/1011 Luxembourg/Luxembourg (1 aut., 3 aut., 4 aut., 6 aut.); Neurosciences Comportementales, URAFPA. INRA UC340, Nancy Université, BP 239/54506 Vandoeuvre les Nancy/France (2 aut., 5 aut.); Department of Immunology, The Graduate School of Psychobiology, University of Trier/54290 Trier/Allemagne (6 aut.); Water Science and Technology Branch, Environmental Canada/Burlington/Canada (1 aut., 3 aut.); Wellington Laboratories/Guelph/Canada (2 aut.); Laboratory Services Branch, Ontario Ministry of Environment/Toronto/Canada (4 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Chemosphere : (Oxford); ISSN 0045-6535; Coden CMSHAF; Royaume-Uni; Da. 2008; Vol. 73; No. SUP1; S295-S302; Bibl. 3/4 p.</SO>
<LA>Anglais</LA>
<EA>Abnormal glutamatergic transmission caused by modulation of N-methyl-D-aspartate (NMDA) receptors was demonstrated in animal models chronically exposed to various organic micropollutants. Recent developments in neurobiology have implicated these receptors in the regulation of anxiety. In order to investigate anxiety-related effects of benzo[a]pyrene (B[a]P), Balb/c mice were sub-acutely exposed to B[a]P (0.02-200 mg kg<sup>-1</sup>
day<sup>-1</sup>
, 10 days, i.p.). Their performance was tested in the elevated-plus maze and the hole-board apparatus and the NMDA receptor expression genes (NR1, 2A and 2B subunits) was measured in eight brain regions. Mice treated with 20-200mg kg<sup>-1</sup>
B[a]P showed a disproportionate accumulation of B[a]P and its metabolites (in particular, the toxic 7,8-diol-B[a]P) in the blood and even more in the brain. These mice were less anxious than controls in the hole-board test and the elevated-plus maze. This observation was associated with an overexpression of the NMDA NR1 receptor gene and concomitant decreases of the NR2A and NR2B subunits expression in the hippocampus, the hypothalamus and the cerebellum. In the temporal cortex, a significant dose-related decrease of NR2A was observed whereas the other subunits remained unchanged. In conclusion, a sub-acute exposure to B[a]P (20 and 200 mg kg<sup>-1</sup>
) reduced anxiety-related behaviour in adult mice and concomitantly impaired NMDA receptor gene expression in relevant brain regions.</EA>
<CC>002B03L06</CC>
<FD>Benzo pyrène; Subaigu; Benzo[a]pyrène; Comportement; Animal adulte; Souris; NMDA; Angoisse anxiété; Récepteur NMDA; Gène; Encéphale; Récepteur glutamate; Sousunité; Sang; Composé aromatique polycyclique; Hydrocarbure; Mécanisme action; Toxicité</FD>
<FG>Rodentia; Mammalia; Vertebrata; Polluant organique persistant; Composé organique; Affect affectivité</FG>
<ED>Benzopyrene; Subacute; Behavior; Adult animal; Mouse; NMDA; Anxiety; NMDA receptor; Gene; Encephalon; Glutamate receptor; Subunit; Blood; Polycyclic aromatic compound; Hydrocarbon; Mechanism of action; Toxicity</ED>
<EG>Rodentia; Mammalia; Vertebrata; Persistent organic pollutant; Organic compounds; Affect affectivity</EG>
<SD>Benzopireno; Subagudo; Conducta; Animal adulto; Ratón; NMDA; Angustia ansiedad; Receptor NMDA; Gen; Encéfalo; Receptor glutámato; Subunitad; Sangre; Compuesto aromático policíclico; Hidrocarburo; Mecanismo acción; Toxicidad</SD>
<LO>INIST-15565.354000185279380450</LO>
<ID>09-0021305</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000740 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000740 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Rhénanie |area= UnivTrevesV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:09-0021305 |texte= Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-D-aspartate (NMDA) receptors genes in relevant brain regions }}
This area was generated with Dilib version V0.6.31. |